No datasets match
  1. 1.
    curatedBreastData::curatedBreastData_pData
    curatedBreastData_pData
    csv| xlsx| json| ndjson| rda| rds
    data.frame|2719 x 153
  2. 2.
    curatedCRCData::GSE11237_eset
    Celecoxib pre-treatment in human colorectal adenocarcinoma patients is associated with gene expression alterations suggestive of diminished cellular proliferation.
    rda| rds
    ExpressionSet
  3. 3.
    curatedCRCData::GSE12225.GPL3676_eset
    Integrating chromosomal aberrations and gene expression profiles to dissect rectal tumorigenesis.
    rda| rds
    ExpressionSet
  4. 4.
    curatedCRCData::GSE12945_eset
    An expression module of WIPF1-coexpressed genes identifies patients with favorable prognosis in three tumor types.
    rda| rds
    ExpressionSet
  5. 5.
    curatedCRCData::GSE13067_eset
    DNA copy-number alterations underlie gene expression differences between microsatellite stable and unstable colorectal cancers.
    rda| rds
    ExpressionSet
  6. 6.
    curatedCRCData::GSE13294_eset
    DNA copy-number alterations underlie gene expression differences between microsatellite stable and unstable colorectal cancers.
    rda| rds
    ExpressionSet
  7. 7.
    curatedCRCData::GSE14095_eset
    Gene expression signature and response to the use of leucovorin, fluorouracil and oxaliplatin in colorectal cancer patients.
    rda| rds
    ExpressionSet
  8. 8.
    curatedCRCData::GSE14333_eset
    Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer.
    rda| rds
    ExpressionSet
  9. 9.
    curatedCRCData::GSE16125.GPL5175_eset
    Integrative approach for prioritizing cancer genes in sporadic colon cancer.
    rda| rds
    ExpressionSet
  10. 10.
    curatedCRCData::GSE17536_eset
    Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer.
    rda| rds
    ExpressionSet
  11. 11.
    curatedCRCData::GSE17537_eset
    Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer.
    rda| rds
    ExpressionSet
  12. 12.
    curatedCRCData::GSE17538.GPL570_eset
    Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer.
    rda| rds
    ExpressionSet
  13. 13.
    curatedCRCData::GSE18105_eset
    MUC12 mRNA expression is an independent marker of prognosis in stage II and stage III colorectal cancer.
    rda| rds
    ExpressionSet
  14. 14.
    curatedCRCData::GSE2109_eset
    Expression Project for Oncology (expO)
    rda| rds
    ExpressionSet
  15. 15.
    curatedCRCData::GSE21510_eset
    Clinical significance of osteoprotegerin expression in human colorectal cancer.
    rda| rds
    ExpressionSet
  16. 16.
    curatedCRCData::GSE21815_eset
    Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers.
    rda| rds
    ExpressionSet
  17. 17.
    curatedCRCData::GSE24549.GPL5175_eset
    Transcriptome instability in colorectal cancer identified by exon microarray analyses: Associations with splicing factor expression levels and patient survival.
    rda| rds
    ExpressionSet
  18. 18.
    curatedCRCData::GSE24550.GPL5175_eset
    Transcriptome instability in colorectal cancer identified by exon microarray analyses: Associations with splicing factor expression levels and patient survival.
    rda| rds
    ExpressionSet
  19. 19.
    curatedCRCData::GSE2630_eset
    A gene signature of 8 genes could identify the risk of recurrence and progression in Dukes' B colon cancer patients.
    rda| rds
    ExpressionSet
  20. 20.
    curatedCRCData::GSE26682.GPL570_eset
    MRE11 deficiency increases sensitivity to poly(ADP-ribose) polymerase inhibition in microsatellite unstable colorectal cancers.
    rda| rds
    ExpressionSet
  21. 21.
    curatedCRCData::GSE26682.GPL96_eset
    MRE11 deficiency increases sensitivity to poly(ADP-ribose) polymerase inhibition in microsatellite unstable colorectal cancers.
    rda| rds
    ExpressionSet
  22. 22.
    curatedCRCData::GSE26906_eset
    Expression Profiles in Stage II Colon Cancer According to APC Gene Status.
    rda| rds
    ExpressionSet
  23. 23.
    curatedCRCData::GSE27544_eset
    Genome-wide profiling characterizes CRCs with genetic instability and specific routes to HLA class I loss and immunoescape
    rda| rds
    ExpressionSet
  24. 24.
    curatedCRCData::GSE28702_eset
    Potential responders to FOLFOX therapy for colorectal cancer by Random Forests analysis.
    rda| rds
    ExpressionSet
  25. 25.
    curatedCRCData::GSE3294_eset
    Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa.
    rda| rds
    ExpressionSet
  26. 26.
    curatedCRCData::GSE33113_eset
    Mutations in the Ras-Raf Axis underlie the prognostic value of CD133 in colorectal cancer.
    rda| rds
    ExpressionSet
  27. 27.
    curatedCRCData::GSE39582_eset
    Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value.
    rda| rds
    ExpressionSet
  28. 28.
    curatedCRCData::GSE3964_eset
    Deciphering cellular states of innate tumor drug responses.
    rda| rds
    ExpressionSet
  29. 29.
    curatedCRCData::GSE4045_eset
    Serrated carcinomas form a subclass of colorectal cancer with distinct molecular basis.
    rda| rds
    ExpressionSet
  30. 30.
    curatedCRCData::GSE4526_eset
    Gene expression signature for recurrence in stage III colorectal cancers.
    rda| rds
    ExpressionSet
  31. 31.
    curatedCRCData::GSE45270_eset
    AMC tubular and serrated adenomas
    rda| rds
    ExpressionSet
  32. 32.
    curatedCRCData::TCGA.COAD_eset
    Comprehensive molecular characterization of human colon and rectal cancer.
    rda| rds
    ExpressionSet
  33. 33.
    curatedCRCData::TCGA.READ_eset
    Comprehensive molecular characterization of human colon and rectal cancer.
    rda| rds
    ExpressionSet
  34. 34.
    curatedCRCData::TCGA.RNASeqV2_eset
    Comprehensive molecular characterization of human colon and rectal cancer.
    rda| rds
    ExpressionSet
  35. 35.
    curatedCRCData::TCGA.RNASeqV2.READ_eset
    Comprehensive molecular characterization of human colon and rectal cancer.
    rda| rds
    ExpressionSet
  36. 36.
    curatedOvarianData::E.MTAB.386_eset
    Angiogenic mRNA and microRNA gene expression signature predicts a novel subtype of serous ovarian cancer.
    rda| rds
    ExpressionSet
  37. 37.
    curatedOvarianData::GSE12418_eset
    Expression analysis of stage III serous ovarian adenocarcinoma distinguishes a sub-group of survivors.
    rda| rds
    ExpressionSet
  38. 38.
    curatedOvarianData::GSE12470_eset
    Gene expression profiling of advanced-stage serous ovarian cancers distinguishes novel subclasses and implicates ZEB2 in tumor progression and prognosis.
    rda| rds
    ExpressionSet
  39. 39.
    curatedOvarianData::GSE13876_eset
    Survival-related profile, pathways, and transcription factors in ovarian cancer.
    rda| rds
    ExpressionSet
  40. 40.
    curatedOvarianData::GSE14764_eset
    A prognostic gene expression index in ovarian cancer - validation across different independent data sets.
    rda| rds
    ExpressionSet
  41. 41.
    curatedOvarianData::GSE17260_eset
    Gene expression profile for predicting survival in advanced-stage serous ovarian cancer across two independent datasets.
    rda| rds
    ExpressionSet
  42. 42.
    curatedOvarianData::GSE18520_eset
    A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2.
    rda| rds
    ExpressionSet
  43. 43.
    curatedOvarianData::GSE19829.GPL570_eset
    Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer.
    rda| rds
    ExpressionSet
  44. 44.
    curatedOvarianData::GSE19829.GPL8300_eset
    Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer.
    rda| rds
    ExpressionSet
  45. 45.
    curatedOvarianData::GSE20565_eset
    A genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancer.
    rda| rds
    ExpressionSet
  46. 46.
    curatedOvarianData::GSE2109_eset
    IGC EXpression Project for Oncology
    rda| rds
    ExpressionSet
  47. 47.
    curatedOvarianData::GSE26193_eset
    miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response.
    rda| rds
    ExpressionSet
  48. 48.
    curatedOvarianData::GSE26712_eset
    A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer.
    rda| rds
    ExpressionSet
  49. 49.
    curatedOvarianData::GSE30009_eset
    Multidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinoma.
    rda| rds
    ExpressionSet
  50. 50.
    curatedOvarianData::GSE30161_eset
    Multi-gene expression predictors of single drug responses to adjuvant chemotherapy in ovarian carcinoma: predicting platinum resistance.
    rda| rds
    ExpressionSet
  51. 51.
    curatedOvarianData::GSE32062.GPL6480_eset
    High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway.
    rda| rds
    ExpressionSet
  52. 52.
    curatedOvarianData::GSE32063_eset
    High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway.
    rda| rds
    ExpressionSet
  53. 53.
    curatedOvarianData::GSE44104_eset
    COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer.
    rda| rds
    ExpressionSet
  54. 54.
    curatedOvarianData::GSE49997_eset
    Validating the impact of a molecular subtype in ovarian cancer on outcomes: a study of the OVCAD Consortium.
    rda| rds
    ExpressionSet
  55. 55.
    curatedOvarianData::GSE51088_eset
    POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer.
    rda| rds
    ExpressionSet
  56. 56.
    curatedOvarianData::GSE6008_eset
    Lysophosphatidic acid-induced transcriptional profile represents serous epithelial ovarian carcinoma and worsened prognosis.
    rda| rds
    ExpressionSet
  57. 57.
    curatedOvarianData::GSE6822_eset
    Classification of ovarian tumor samples
    rda| rds
    ExpressionSet
  58. 58.
    curatedOvarianData::GSE8842_eset
    Analysis of gene expression in early-stage ovarian cancer.
    rda| rds
    ExpressionSet
  59. 59.
    curatedOvarianData::GSE9891_eset
    Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.
    rda| rds
    ExpressionSet
  60. 60.
    curatedOvarianData::PMID15897565_eset
    Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers.
    rda| rds
    ExpressionSet
  61. 61.
    curatedOvarianData::PMID17290060_eset
    An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.
    rda| rds
    ExpressionSet
  62. 62.
    curatedOvarianData::PMID19318476_eset
    Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcome.
    rda| rds
    ExpressionSet
  63. 63.
    curatedOvarianData::TCGA_eset
    Integrated genomic analyses of ovarian carcinoma.
    rda| rds
    ExpressionSet
  64. 64.
    curatedOvarianData::TCGA.mirna.8x15kv2_eset
    Integrated genomic analyses of ovarian carcinoma.
    rda| rds
    ExpressionSet
  65. 65.
    curatedOvarianData::TCGA.RNASeqV2_eset
    Integrated genomic analyses of ovarian carcinoma.
    rda| rds
    ExpressionSet
  66. 66.
    curatedOvarianData::E.MTAB.386_eset
    Angiogenic mRNA and microRNA gene expression signature predicts a novel subtype of serous ovarian cancer.
    rda| rds
    ExpressionSet
  67. 67.
    curatedOvarianData::GSE12418_eset
    Expression analysis of stage III serous ovarian adenocarcinoma distinguishes a sub-group of survivors.
    rda| rds
    ExpressionSet
  68. 68.
    curatedOvarianData::GSE12470_eset
    Gene expression profiling of advanced-stage serous ovarian cancers distinguishes novel subclasses and implicates ZEB2 in tumor progression and prognosis.
    rda| rds
    ExpressionSet
  69. 69.
    curatedOvarianData::GSE13876_eset
    Survival-related profile, pathways, and transcription factors in ovarian cancer.
    rda| rds
    ExpressionSet
  70. 70.
    curatedOvarianData::GSE14764_eset
    A prognostic gene expression index in ovarian cancer - validation across different independent data sets.
    rda| rds
    ExpressionSet
  71. 71.
    curatedOvarianData::GSE17260_eset
    Gene expression profile for predicting survival in advanced-stage serous ovarian cancer across two independent datasets.
    rda| rds
    ExpressionSet
  72. 72.
    curatedOvarianData::GSE18520_eset
    A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2.
    rda| rds
    ExpressionSet
  73. 73.
    curatedOvarianData::GSE19829.GPL570_eset
    Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer.
    rda| rds
    ExpressionSet
  74. 74.
    curatedOvarianData::GSE19829.GPL8300_eset
    Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer.
    rda| rds
    ExpressionSet
  75. 75.
    curatedOvarianData::GSE20565_eset
    A genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancer.
    rda| rds
    ExpressionSet
  76. 76.
    curatedOvarianData::GSE2109_eset
    IGC EXpression Project for Oncology
    rda| rds
    ExpressionSet
  77. 77.
    curatedOvarianData::GSE26193_eset
    miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response.
    rda| rds
    ExpressionSet
  78. 78.
    curatedOvarianData::GSE26712_eset
    A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer.
    rda| rds
    ExpressionSet
  79. 79.
    curatedOvarianData::GSE30009_eset
    Multidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinoma.
    rda| rds
    ExpressionSet
  80. 80.
    curatedOvarianData::GSE30161_eset
    Multi-gene expression predictors of single drug responses to adjuvant chemotherapy in ovarian carcinoma: predicting platinum resistance.
    rda| rds
    ExpressionSet
  81. 81.
    curatedOvarianData::GSE32062.GPL6480_eset
    High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway.
    rda| rds
    ExpressionSet
  82. 82.
    curatedOvarianData::GSE32063_eset
    High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway.
    rda| rds
    ExpressionSet
  83. 83.
    curatedOvarianData::GSE44104_eset
    COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer.
    rda| rds
    ExpressionSet
  84. 84.
    curatedOvarianData::GSE49997_eset
    Validating the impact of a molecular subtype in ovarian cancer on outcomes: a study of the OVCAD Consortium.
    rda| rds
    ExpressionSet
  85. 85.
    curatedOvarianData::GSE51088_eset
    POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer.
    rda| rds
    ExpressionSet
  86. 86.
    curatedOvarianData::GSE6008_eset
    Lysophosphatidic acid-induced transcriptional profile represents serous epithelial ovarian carcinoma and worsened prognosis.
    rda| rds
    ExpressionSet
  87. 87.
    curatedOvarianData::GSE6822_eset
    Classification of ovarian tumor samples
    rda| rds
    ExpressionSet
  88. 88.
    curatedOvarianData::GSE8842_eset
    Analysis of gene expression in early-stage ovarian cancer.
    rda| rds
    ExpressionSet
  89. 89.
    curatedOvarianData::GSE9891_eset
    Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.
    rda| rds
    ExpressionSet
  90. 90.
    curatedOvarianData::PMID15897565_eset
    Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers.
    rda| rds
    ExpressionSet
  91. 91.
    curatedOvarianData::PMID17290060_eset
    An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.
    rda| rds
    ExpressionSet
  92. 92.
    curatedOvarianData::PMID19318476_eset
    Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcome.
    rda| rds
    ExpressionSet
  93. 93.
    curatedOvarianData::TCGA_eset
    Integrated genomic analyses of ovarian carcinoma.
    rda| rds
    ExpressionSet
  94. 94.
    curatedOvarianData::TCGA.mirna.8x15kv2_eset
    Integrated genomic analyses of ovarian carcinoma.
    rda| rds
    ExpressionSet
  95. 95.
    curatedOvarianData::TCGA.RNASeqV2_eset
    Integrated genomic analyses of ovarian carcinoma.
    rda| rds
    ExpressionSet